The Leona M and Harry B Helmsley

What they fund

diseasecrohnshealthdiabetescentertypeultrasoundcare

Funding pattern

What this funder pays for, at what size, and how to position adjacent work. Read from their filings, with every number checked against the record.

200 grants matching “crohn” · $134.1M

• $3.5M

  The Broad Institute · Cambridge, MA · 2024

  Novel therapeutic approaches for crohns disease

• $2.9M

  Mass General Brigham for the Brigham and Women'S Hospital · Boston, MA · 2024

  Real-time post-op touchless, remote monitoring in crohns disease the sapphire trial

• $2.3M

  Icahn School of Medicine at Mount Sinai · New York City, NY · 2024

  Defining the pre-disease phase of crohns disease predict and prevent

• $1.8M

  The Bionics Institute of Australia · 2024

  Patient-specific adaptive, electric therapy for crohns disease

• $1.7M

  Mass General Brigham for the Massachusetts General Hospital · Boston, MA · 2024

  Microbes, molecules, and chemistry dysbiosis in crohns disease

• $1.6M

  Crohn'S & Colitis Foundation · New York, NY · 2024

  Achieving remission in ibd optimizing treat-to-target in clinical practice

• $1.5M

  Amsterdam Umc Research Bv · 2024

  A prospective randomized study of treatment selection based on epigenetic markers in crohns disease omicrohn

• $1.5M

  The Chancellor Masters and Scholars of the University of Cambridge · 2024

  New insights into crohn's disease from studying naked mole rats

• $1.5M

  Katholieke Universiteit Te Leuven · 2024

  Fat as a villain in crohn's disease.

• $1.4M

  Mass General Brigham for the Massachusetts General Hospital · Boston, MA · 2024

  Validation of wireless thermal and microscopic imaging technology for quantifying inflammation and fibrosis in crohns disease

• $1.2M

  Crohn'S & Colitis Foundation · New York, NY · 2024

  Ibd ventures academic incubator

• $1.2M

  International Bowel Ultrasound Group Ev · 2024

  Development of an intestinal ultrasound score to evaluate inflammation and treatment response in crohns disease.

• $1.1M

  Children'S Hospital Medical Center · Cincinnati, OH · 2024

  Artificial intelligence prediction of meaningful outcomes in newly diagnosed small bowel crohns disease

• $1.1M

  The Regents of the University of California San Diego · La Jolla, CA · 2024

  The druggable gpcrome in crohns disease

• $1.1M

  Regents of University of California Berkeley · Berkeley, CA · 2024

  Developing microbiome editing tools to advance understanding of the microbial influence on crohn's disease

• $1.0M

  The Imperial College of Science Technology and Medicine · 2024

  Unraveling the immunopathology of perianal fistulizing crohns disease

• $993,497

  Icahn School of Medicine at Mount Sinai · New York City, NY · 2024

  The use of glp-1r agonists to promote epithelial healing in crohns disease

• $971,014

  The Broad Institute · Cambridge, MA · 2024

  Uncovering crohn's genetic risk in african-american and hispanic/latino populations

• $920,802

  Icahn School of Medicine at Mount Sinai · New York City, NY · 2024

  Spatial mapping of fibromuscular crohns disease from genetic to senescent signals

• $871,250

  Crohn'S Colitis Cure · 2024

  Enhancing inflammatory bowel disease care consumer-centric portal for better communication & reduced navigation stress

• $863,618

  Cornell University for the Joan & Sanford I Weill Medical College · New York, NY · 2024

  Targeting the mycobiome in patients with crohns disease

• $808,734

  The Chancellor Masters and Scholars of the University of Cambridge · 2024

  Does the western diet trigger crohn's disease via osmotic stress?

• $756,699

  The Sheba Fund for Health Services and Research · 2024

  Israel ibd research nucleus (iirn) consortium capsule & omics for predicting exacerbation of crohns disease (core-cd)

• $750,000

  Johns Hopkins University · Baltimore, MD · 2024

  Engineered cytokine/antibody fusion protein to treat crohns disease

• $744,245

  Crohn'S & Colitis Foundation · New York, NY · 2024

  Accelerating enrollment in ibd clinical trials

• $682,311

  The University of Edinburgh · 2024

  Mitochondrial damps as mechanistic biomarkers of mucosal inflammation in crohns disease (music)

• $667,666

  Board of Trustees of the Leland Stanford Junior University · Stanford, CA · 2024

  Determining the therapeutic potential of statins on stricturing crohns disease

• $618,257

  Icahn School of Medicine at Mount Sinai · New York City, NY · 2024

  Early life exposome biomarkers and crohn's disease risk the early-cd project

• $612,471

  Chancellor Masters & Scholars of the University of Oxford · 2024

  Defining the signaling circuits and regulons mediating crohns fibrosis.

• $599,035

  Yale University · New Haven, CT · 2024

  Targeting newly discovered host-microbiota interaction nodes to treat or prevent crohns disease

• $583,881

  Icahn School of Medicine at Mount Sinai · New York City, NY · 2024

  Development of novel lrrk2 inhibitors to treat crohns disease

• $583,113

  Children'S Hospital Medical Center · Cincinnati, OH · 2024

  Validation of a peripheral blood biomarker signature for anti-tnf response in patients with crohns disease (atpbios)

• $523,716

  Icahn School of Medicine at Mount Sinai · New York City, NY · 2024

  Combination therapy of resilience intervention with biologics in crohns disease [catharsis trial]

• $488,300

  Washington University · Saint Louis, MO · 2024

  Cellular biomarkers for pediatric crohns disease

• $485,616

  Georgia Tech Research Corporation · Atlanta, GA · 2024

  Longitudinal tracking and reference-based interpretation of single-cell characteristics in treatment nave patients with crohns disease

• $473,409

  University of Massachusetts Medical School · Worcester, MA · 2024

  Dieta anti-inflamatoria a crohns disease management strategy tailored for puerto ricans

• $469,915

  Alimentiv · 2024

  Validation of the pro symptoms and impacts questionnaire for crohns disease

• $467,726

  Crohn'S and Colitis UK · 2024

  Implementation of a lower gi diagnostic pathway in primary healthcare and development and dissemination of a lower gi patient toolkit

• $463,512

  Clalit Health Services · 2024

  Israeli ibd research nucleus (iirn) consortium biomarker-based multidisciplinary team approach to improve early crohn's disease outcomes

• $457,178

  The Regents of the University of Colorado Denver · Aurora, CO · 2024

  Epithelial mitochondrial dysfunction and extracellular vesicles in crohns disease fibrostenosis.

• $429,646

  The Trustees of Columbia University in the City of New York · New York, NY · 2024

  Combinatorial perturbation of cellular network in crohns disease

• $426,571

  Katholieke Universiteit Te Leuven · 2024

  Targeting chronic inflammation and tissue remodelling in crohn's disease with engineered t cells

• $421,278

  Federal Institute of Technology Zurich Ethz · 2024

  Spatial biology of crohns colitis

• $413,263

  The Trustees of Columbia University in the City of New York · New York, NY · 2024

  Combinatorial perturbation of cellular network in crohns disease

• $413,016

  Yale University · New Haven, CT · 2024

  Exposomics for early life crohns disease

• $402,672

  Genome Research Limited for the Wellcome Sanger Institute · 2024

  Scibd-response massive-scale single-cell rna-sequencing to identify transcriptomic predictors of response to biologic therapies in crohns disease

• $394,365

  The Governors of the University of Calgary · 2024

  A drug-wide scan to identify repurposed medications for crohn's disease

• $387,615

  The Cleveland Clinic Foundation · Cleveland, OH · 2024

  Mechanobiology of the intestinal epithelial barrier disruption in crohns disease

• $384,292

  King'S College London · 2024

  Resolving harmful accumulation of innate lymphoid cells during crohns disease.

• $374,912

  Crohn'S and Colitis Canada · 2024

  Implementation of nationwide telemedicine network to mitigate geographic disparities in access to healthcare for cd patients living in canada

• $342,493

  Crohn'S & Colitis Foundation · New York, NY · 2024

  Application of machine learning to precision nutrition in crohns disease

• $318,978

  Palo Alto Veterans Institute for Research · Palo Alto, CA · 2024

  Cell atlas of human intestinal lymphoid tissues and changes in crohn's disease

• $315,421

  Australasian Gastro Intestinal Research Foundation Ltd · 2024

  Fecal microbiota transplantation (fmt) in crohn's disease the miro (microbiota restoration) study.

• $310,748

  Crohn'S & Colitis Foundation · New York, NY · 2024

  International consortium on medical nutrition in ibd

• $297,612

  Crohn'S and Colitis Canada · 2024

  Implementing a multimodal rct intervention to improve the transition of patients with crohns disease from pediatric to adult care

• $237,102

  University of Pittsburgh · Pittsburgh, PA · 2024

  Single cell multimodal omics analysis of colonoscopic biopsy-derived immune cells in crohns disease

• $235,000

  Crohn'S & Colitis Foundation · New York, NY · 2024

  Sponsorship for the 2025 crohns & colitis congress presented by the crohns & colitis foundation and the american gastroenterological association

• $221,500

  Hebrew University of Jerusalem · 2024

  Methylation patterns of cell-free dna as a novel biomarker in crohns disease

• $209,377

  Australasian Gastro Intestinal Research Foundation Ltd · 2024

  Fecal microbiota transplantation (fmt) in crohn's disease the miro (microbiota restoration) study.

• $209,222

  The University of Edinburgh · 2024

  Human gut cell atlas - normal intestine and crohn's disease

• $200,927

  University of Texas System for the University of Texas at Austin · Austin, TX · 2024

  Increasing access to crohns disease clinical care for the ibd center at ut health austin

• $198,646

  University of Texas System for the University of Texas at Austin · Austin, TX · 2024

  Increasing access to crohns disease clinical care for the ibd center at ut health austin

• $187,672

  Genome Research Limited for the Wellcome Sanger Institute · 2024

  Scibd-response massive-scale single-cell rna-sequencing to identify transcriptomic predictors of response to biologic therapies in crohns disease

• $176,239

  University of Glasgow Court · 2024

  Combination therapy with biologics and partial enteral nutrition in adults with active ileocolonic crohns disease the biopic study

• $149,796

  University of North Carolina at Chapel Hill · Chapel Hill, NC · 2024

  Genomic and microbial signatures predict post-operative crohns disease outcomes

• $118,210

  The Sheba Fund for Health Services and Research · 2024

  The utility of hand-held ultrasound devices to detect bowel wall inflammatory activity in crohn's disease

• $94,386

  Centre Hospitalier Regional De Nancy · 2024

  Prevention of extra-intestinal manifestations and comorbidities in crohns disease the nemo project

• $92,033

  Regents of the University of Michigan · Ann Arbor, MI · 2024

  Evaluation of a gut-specific antifibrotic therapeutic in pre-clinical models of crohns disease

• $47,977

  The University of Edinburgh · 2024

  Building a cross-discipline scientific approach towards understanding crohns disease - leveraging uk helmsley studies

• $24,288

  St Mark'S Hospital Foundation · 2024

  Global perianal crohn's disease priority setting partnership

• $1.7M

  Mass General Brigham for the Massachusetts General Hospital · Boston, MA · 2023

  Microbes, molecules, and chemistry: dysbiosis in crohns disease

• $1.6M

  Icahn School of Medicine at Mount Sinai · New York City, NY · 2023

  Defining the pre-disease phase of crohns disease: predict and prevent

• $1.6M

  Amc Medical Research Bv · 2023

  A prospective randomized study of treatment selection based on epigenetic markers in crohns disease: omicrohn

• $1.5M

  The Broad Institute · Cambridge, MA · 2023

  Novel therapeutic approaches for crohns disease

• $1.4M

  Children'S Hospital Medical Center · Cincinnati, OH · 2023

  Artificial intelligence prediction of meaningful outcomes in newly diagnosed small bowel crohns disease

• $1.2M

  University of Glasgow Court · 2023

  Combination therapy with biologics and partial enteral nutrition in adults with active ileocolonic crohns disease: the biopic study

• $1.2M

  Cambridge University Hospitals Nhs Foundation Trust · 2023

  The uk ibd bioresource: translating todays science into tomorrows treatments in crohns disease

• $1.2M

  Regents of University of California Berkeley · Berkeley, CA · 2023

  Developing microbiome editing tools to advance understanding of the microbial influence on crohn's disease

• $1.2M

  Rambam Health Corporation · 2023

  Microbial and dietary effects on immune composition and function in patients with crohn's

• $1.2M

  Crohn'S & Colitis Foundation · New York, NY · 2023

  Ibd ventures academic incubator

• $1.1M

  The University of Manchester · 2023

  A map of the intestine following regulatory t cell infusion into patients with active crohns disease at single-cell and spatial resolution

• $1.1M

  Icahn School of Medicine at Mount Sinai · New York City, NY · 2023

  Spatial mapping of fibromuscular crohns disease: from genetic to senescent signals

• $1.1M

  Crohn'S & Colitis Foundation · New York, NY · 2023

  Training awards program - class of 2021

• $1.0M

  University of Cambridge · 2023

  Does biochemistry at the centre of life drive crohn's disease?

• $1.0M

  Board of Trustees of the Leland Stanford Junior University · Stanford, CA · 2023

  Microbiome-based therapeutics for crohns disease

• $988,042

  Regents of the University of Minnesota · Minneapolis, MN · 2023

  Standardized microbiota transplant therapy in crohns disease. Pilot trial.

• $961,620

  The Weizmann Institute of Science · 2023

  Decoding the clinical impact of host and microbial intestinal proteomic landscape in crohns disease

• $947,483

  The Weizmann Institute of Science · 2023

  Decoding personalized nutritional, microbiome and host patterns impacting clinical and prognostic features in crohns disease

• $881,959

  University of Massachusetts Medical School · Worcester, MA · 2023

  Dieta anti-inflamatoria: a crohns disease management strategy tailored for puerto ricans

• $836,979

  Board of Trustees of the Leland Stanford Junior University · Stanford, CA · 2023

  Investigating the role of the human exposome in crohns disease

• $797,851

  Beth Israel Deaconess Medical Center · Boston, MA · 2023

  Proactive optimization of infliximab using a pharmacokinetic dashboard versus standard of care in patients with crohns disease: the optimize trial

• $792,237

  Yale University · New Haven, CT · 2023

  Targeting newly discovered host-microbiota interaction nodes to treat or prevent crohns disease

• $770,816

  Katholieke Universiteit Te Leuven · 2023

  Combination therapy of diet with biologicals for crohns disease: the oats study

• $759,619

  Icahn School of Medicine at Mount Sinai · New York City, NY · 2023

  The melody trial: modulating early life microbiome through dietary intervention in crohn's disease

• $752,326

  Mass General Brigham for the Massachusetts General Hospital · Boston, MA · 2023

  Wireless infrared imaging capsule for pinpointing inflammation in crohns disease

• $713,088

  University of Cambridge · 2023

  Epigenetic regulation of intestinal epithelial mhc class 1 signalling - anovel mechanism in the pathogenesis of crohns disease

• $712,850

  Crohn'S & Colitis Foundation · New York, NY · 2023

  Accelerating enrollment in ibd clinical trials

• $705,894

  Mass General Brigham for the Massachusetts General Hospital · Boston, MA · 2023

  Crohn's disease in south asians: defining disease biology for prevention and better treatment

• $704,764

  The Sheba Fund for Health Services and Research (Ra) · 2023

  Israel ibd research nucleus (iirn) consortium: capsule & omics for predicting exacerbation of crohns disease (core-cd)

• $642,744

  Cork University Foundation · 2023

  Endoscopic multimodal assessment using advanced imaging integrated ai to predict recurrence in post-operative crohns disease - prospers

• $595,677

  Crohn'S & Colitis Foundation · New York, NY · 2023

  Application of machine learning to precision nutrition in crohns disease

• $588,266

  Crohn'S & Colitis Foundation · New York, NY · 2023

  Systematizing improvement interventions of urgent care management in crohns disease

• $583,311

  University of Cambridge · 2023

  Does the western diet trigger crohn's disease via osmotic stress?

• $581,625

  University of North Carolina at Chapel Hill · Chapel Hill, NC · 2023

  Genomic and microbial signatures predict post-operative crohns disease outcomes

• $568,782

  Johns Hopkins University · Baltimore, MD · 2023

  Targeted, sustained release antifibrotic therapies for crohns disease patients

• $562,426

  Crohn'S and Colitis Canada · 2023

  Implementation of nationwide telemedicine network to mitigate geographic disparities in access to healthcare for cd patients living in canada

• $536,228

  Federal Institute of Technology Zurich Ethz · 2023

  Spatial biology of crohns colitis

• $531,295

  King'S College London · 2023

  Identifying the role of food additive emulsifiers in crohn's disease: a randomized controlled trial

• $499,459

  Mass General Brigham for the Brigham and Women'S Hospital · Boston, MA · 2023

  Investigation of anti-gm-csf autoantibodies as a disease determinant in crohns disease

• $494,231

  The Scripps Research Institute · La Jolla, CA · 2023

  Translation of microbiota mechanisms on nod2 for crohns disease therapies

• $485,617

  Georgia Tech Research Corporation · Atlanta, GA · 2023

  Longitudinal tracking and reference-based interpretation of single-cell characteristics in treatment nave patients with crohns disease

• $480,848

  Georgia Tech Research Corporation · Atlanta, GA · 2023

  Longitudinal tracking and reference-based interpretation of single-cell characteristics in treatment nave patients with crohns disease

• $452,465

  Clalit Health Services · 2023

  Israeli ibd research nucleus (iirn) consortium: biomarker-based multidisciplinary team approach to improve early crohn's disease outcomes

• $447,521

  King'S College London · 2023

  Resolving harmful accumulation of innate lymphoid cells during crohns disease.

• $444,246

  The University of Edinburgh · 2023

  Human gut cell atlas - normal intestine and crohn's disease

• $429,712

  The Cleveland Clinic Foundation · Cleveland, OH · 2023

  Mechanobiology of the intestinal epithelial barrier disruption in crohns disease

• $414,595

  Yale University · New Haven, CT · 2023

  Exposomics for early life crohns disease

• $410,936

  Australasian Gastro Intestinal Research Foundation Ltd · 2023

  Fecal microbiota transplantation (fmt) in crohn's disease: the miro (microbiota restoration) study.

• $404,688

  Icahn School of Medicine at Mount Sinai · New York City, NY · 2023

  Next phase of stem cell transplant for refractory crohns disease

• $397,123

  Genome Research Limited for the Wellcome Sanger Institute · 2023

  Scibd-response: massive-scale single-cell rna-sequencing to identify transcriptomic predictors of response to biologic therapies in crohns disease

• $374,591

  Children'S Hospital Corporation · Boston, MA · 2023

  Molecular and spatial single-cell remodeling in pediatric crohns disease

• $369,880

  Regents of the University of Michigan · Ann Arbor, MI · 2023

  Using natural language processing of clinical documentation to improve personalization of care in crohn's disease

• $367,129

  Aphp St Antoine Hospital · 2023

  Fecal microbiota transplantation in crohn's disease as relay after anti-tnf withdrawal (miracle)

• $362,703

  Hebrew University of Jerusalem · 2023

  Methylation patterns of cell-free dna as a novel biomarker in crohns disease

• $351,258

  The Trustees of Columbia University in the City of New York · New York, NY · 2023

  Combinatorial perturbation of cellular network in crohns disease

• $338,970

  Washington University · Saint Louis, MO · 2023

  Cellular biomarkers for pediatric crohns disease

• $334,798

  The Trustees of Columbia University in the City of New York · New York, NY · 2023

  Combinatorial perturbation of cellular network in crohns disease

• $305,349

  Icahn School of Medicine at Mount Sinai · New York City, NY · 2023

  Next phase of stem cell transplant for refractory crohns disease

• $298,606

  Yale University · New Haven, CT · 2023

  Exposomics for early life crohns disease

• $293,370

  Trustees of the University of Pennsylvania · Philadelphia, PA · 2023

  The ultra processed western diet, the gut microbiome, and dietary xenobiotic exposure in crohns disease

• $292,821

  Palo Alto Veterans Institute for Research · Palo Alto, CA · 2023

  Cell atlas of human intestinal lymphoid tissues and changes in crohn's disease

• $290,049

  Vanderbilt University Medical Center · Nashville, TN · 2023

  Combinatorial single cell strategies for a crohn's disease gut cell atlas

• $285,079

  Trustees of the University of Pennsylvania · Philadelphia, PA · 2023

  The ultra processed western diet, the gut microbiome, and dietary xenobiotic exposure in crohns disease

• $284,646

  Crohn'S and Colitis Canada · 2023

  Implementing a multimodal rct intervention to improve the transition of patients with crohns disease from pediatric to adult care

• $280,115

  University of Pittsburgh · Pittsburgh, PA · 2023

  Single cell multimodal omics analysis of colonoscopic biopsy-derived immune cells in crohns disease

• $260,103

  University of North Carolina at Chapel Hill · Chapel Hill, NC · 2023

  Frequency and titer of granulocyte-macrophage colony-stimulating factor auto-antibodies in patients with crohn's-like disease of the pouch

• $251,522

  Genome Research Limited for the Wellcome Sanger Institute · 2023

  Scibd-response: massive-scale single-cell rna-sequencing to identify transcriptomic predictors of response to biologic therapies in crohns disease

• $247,654

  The Governors of the University of Calgary · 2023

  Quantitative proteomic profiling of fibrostenotic crohns disease patients

• $243,196

  University of Pittsburgh · Pittsburgh, PA · 2023

  Single cell multimodal omics analysis of colonoscopic biopsy-derived immune cells in crohns disease

• $221,420

  Chancellor Masters & Scholars of the University of Oxford · 2023

  Interrogating the mechanism of hypersensitivity to antibody-based drugs for development of a novel anti-tnf biologic for crohns disease

• $212,881

  The University of Edinburgh · 2023

  Human gut cell atlas - normal intestine and crohn's disease

• $200,000

  Crohn'S & Colitis Foundation · New York, NY · 2023

  Sponsorship for the 2024 crohns & colitis congress presented by the crohns & colitis foundation and the american gastroenterological association

• $198,646

  University of Texas System for the University of Texas at Austin · Austin, TX · 2023

  Increasing access to crohns disease clinical care for the ibd center at ut health austin

• $197,373

  Amc Medical Research Bv · 2023

  Development and validation of an epigenetic biomarker that predicts treatment success and allows personalized management in crohns disease

• $196,411

  University of Texas System for the University of Texas at Austin · Austin, TX · 2023

  Increasing access to crohns disease clinical care for the ibd center at ut health austin

• $195,494

  King'S College London · 2023

  Identifying the role of food additive emulsifiers in crohn's disease: a randomized controlled trial

• $191,883

  The Governors of the University of Calgary · 2023

  The changing epidemiology and demographics of crohns disease in the western world over the next decade

• $187,370

  Regents of the University of Michigan · Ann Arbor, MI · 2023

  Evaluation of a gut-specific antifibrotic therapeutic in pre-clinical models of crohns disease

• $172,204

  The University of Edinburgh · 2023

  Mitochondrial damps as mechanistic biomarkers of mucosal inflammation in crohns disease (music)

• $149,796

  University of North Carolina at Chapel Hill · Chapel Hill, NC · 2023

  Genomic and microbial signatures predict post-operative crohns disease outcomes

• $142,264

  Regents of the University of Michigan · Ann Arbor, MI · 2023

  A system biology approach to understanding persistent symptoms in quiescent crohns disease

• $121,036

  The Governors of the University of Calgary · 2023

  The changing epidemiology and demographics of crohns disease in the western world over the next decade

• $115,418

  Crohn'S Colitis Cure · 2023

  Development of "cccare-p", a pediatric-specific crohns disease electronic medical record to drive care consistency and enhance transitions in care

• $111,750

  The Cleveland Clinic Foundation · Cleveland, OH · 2023

  Development of an intestinal ultrasound index and a histopathology index for stricturing small bowel crohns disease

• $106,296

  The University of Chicago · Chicago, IL · 2023

  Immuno-pharmacogenomics to understand and predict response to biologics in crohn's disease

• $95,277

  Centre Hospitalier Regional De Nancy · 2023

  Prevention of extra-intestinal manifestations and comorbidities in crohns disease: the nemo project

• $89,047

  The Governors of the University of Calgary · 2023

  Visualization of covid-19 vaccine serology in crohns disease: a knowledge translation strategy

• $88,791

  Children'S Hospital Medical Center · Cincinnati, OH · 2023

  Precision crohns disease management utilizing predictive protein panels

• $83,381

  Asian Health Care Foundation · 2023

  Improving access to diagnostics for crohn's disease patients living below the poverty line in southern india

• $75,900

  Crohn'S and Colitis UK · 2023

  2021 & 2022 operating support for crohn's and colitis uk: knowledge and evidence personnel

• $60,060

  Health Advocacy Summit · Greenwood, IN · 2023

  Crohns and colitis young adults network learning community, roundtable on adolescents and young adults with ibd

• $60,000

  University College London · 2023

  Spit-c: using saliva to predict crohns disease

• $1.5M

  The Broad Institute · Cambridge, MA · 2022

  Novel therapeutic approaches for crohns disease

• $1.3M

  The Cleveland Clinic Foundation · Cleveland, OH · 2022

  Crohns fistulizing program investigator initiated clinical trials

• $1.3M

  The Weizmann Institute of Science · 2022

  Decoding personalized nutritional, microbiome and host patterns impacting clinical and prognostic features in crohns disease

• $1.3M

  The Regents of the University of California San Diego · La Jolla, CA · 2022

  The druggable gpcrome in crohns disease

• $1.3M

  Klinikum Der Ludwig-Maximilians-Universitat Munchen · 2022

  Fecal microbiota transfer for maintenance of remission after induction treatment with exclusive enteral nutrition in crohns disease

• $1.2M

  Brigham and Women'S Hospital · Boston, MA · 2022

  Investigation of anti-gm-csf autoantibodies as a disease determinant in crohns disease

• $1.2M

  Crohn'S & Colitis Foundation · New York, NY · 2022

  Ibd ventures academic incubator

• $1.2M

  The University of Manchester · 2022

  A map of the intestine following regulatory t cell infusion into patients with active crohns disease at single-cell and spatial resolution

• $1.1M

  Crohn'S & Colitis Foundation · New York, NY · 2022

  Training awards program - class of 2021

• $1.1M

  Ben-Gurion University of the Negev · 2022

  Cobmindex goes forward- a smartphone application for added psychological wellbeing in crohn's disease.

• $1.0M

  New York University · New York, NY · 2022

  Identifying environmental contributors to crohn's disease

• $1.0M

  Board of Trustees of the Leland Stanford Junior University · Stanford, CA · 2022

  Microbiome-based therapeutics for crohns disease

• $997,937

  The Imperial College of Science Technology and Medicine · 2022

  Unraveling the immunopathology of perianal fistulizing crohns disease

• $956,452

  The Broad Institute · Cambridge, MA · 2022

  Uncovering crohn's genetic risk in african-american and hispanic/latino populations

• $955,956

  Cambridge University Hospitals Nhs Foundation Trust · 2022

  The uk ibd bioresource: translating todays science into tomorrows treatments in crohns disease

• $954,604

  The Cleveland Clinic Foundation · Cleveland, OH · 2022

  Crohns fistulizing program investigator initiated clinical trials

• $951,750

  Rambam Health Corporation · 2022

  Microbial and dietary effects on immune composition and function in patients with crohn's

• $863,618

  Weill Medical College of Cornell University · New York, NY · 2022

  Targeting the mycobiome in patients with crohns disease

• $843,986

  Massachusetts General Hospital · Boston, MA · 2022

  Wireless infrared imaging capsule for pinpointing inflammation in crohns disease

• $798,066

  The Sheba Fund for Health Services and Research (Ra) · 2022

  Israel ibd research nucleus (iirn) consortium: capsule & omics for predicting exacerbation of crohns disease (core-cd)

• $779,377

  International Bowel Ultrasound Group Ev · 2022

  Development of an intestinal ultrasound score to evaluate inflammation and treatment response in crohns disease.

• $750,000

  Johns Hopkins University · Baltimore, MD · 2022

  Engineered cytokine/antibody fusion protein to treat crohns disease

• $718,578

  International Bowel Ultrasound Group Ev · 2022

  Development of an intestinal ultrasound score to evaluate inflammation and treatment response in crohns disease.

• $711,485

  University of Cambridge · 2022

  Epigenetic regulation of intestinal epithelial mhc class 1 signalling - a novel mechanism in the pathogenesis of crohns disease

• $701,115

  The Weizmann Institute of Science · 2022

  Decoding the clinical impact of host and microbial intestinal proteomic landscape in crohns disease

• $698,657

  Brigham and Women'S Hospital · Boston, MA · 2022

  Investigation of anti-gm-csf autoantibodies as a disease determinant in crohns disease

• $690,953

  Board of Trustees of the Leland Stanford Junior University · Stanford, CA · 2022

  Investigating the role of the human exposome in crohns disease

• $672,494

  University of Glasgow Court · 2022

  Combination therapy with biologics and partial enteral nutrition in adults with active ileocolonic crohns disease: the biopic study

• $671,024

  Hebrew University of Jerusalem · 2022

  Methylation patterns of cell-free dna as a novel biomarker in crohns disease

• $656,542

  Katholieke Universiteit Leuven · 2022

  Combination therapy of diet with biologicals for crohns disease: the oats study

• $656,092

  Vanderbilt University Medical Center · Nashville, TN · 2022

  Combinatorial single cell strategies for a crohn's disease gut cell atlas

• $618,790

  The University of Edinburgh · 2022

  Mitochondrial damps as mechanistic biomarkers of mucosal inflammation in crohns disease (music)

• $599,718

  Clalit Health Services · 2022

  Biomarker-based multidisciplinary team (bio-mdt) approach to personalized microbial-targeted treatment of pouchitis and crohn's disease

• $587,840

  Australasian Gastro Intestinal Research Foundation Ltd · 2022

  Fecal microbiota transplantation in crohn's disease: the miro study to improve health outcomes

• $585,750

  University of North Carolina at Chapel Hill · Chapel Hill, NC · 2022

  Genomic and microbial signatures predict post-operative crohns disease outcomes

• $570,831

  Crohn'S & Colitis Foundation · New York, NY · 2022

  Systematizing improvement interventions of urgent care management in crohns disease

• $570,830

  Crohn'S & Colitis Foundation · New York, NY · 2022

  Systematizing improvement interventions of urgent care management in crohns disease

• $562,008

  Johns Hopkins University · Baltimore, MD · 2022

  Targeted, sustained release antifibrotic therapies for crohns disease patients

Top recipients

Repeat recipients are the strongest signal of whether a funder has an open door or quietly re-funds the same organizations.

• Helmholtz Zentrum Munchen (Gmbh)42 grants · $52.3M
• Blue Circle Health11 grants · $45.4M
• Shaare Zedek Medical Center22 grants · $42.6M
• Clalit Health Services37 grants · $41.7M
• American Heart Association20 grants · $30.7M
• Regents of the University of Minnesota16 grants · $30.4M
• The End Fund4 grants · $30.0M
• The Regents of the University of Colorado Denver49 grants · $22.5M
• Mass General Brigham for the Brigham and Women'S Hospital7 grants · $21.5M
• Catholic Relief Services-Usccb13 grants · $21.4M

Giving over time

Grant history

The 100 largest of 2,251 grants.

• $22.5M

  The End Fund · New York, NY · 2022

  Neglected tropical disease: reaching the last mile

• $15.6M

  Blue Circle Health · Wilmington, DE · 2021

  Creation of blue circle health for underserved communities with t1d

• $12.6M

  Regents of the University of Minnesota · Minneapolis, MN · 2021

  Minnesota first responder aed project

• $9.9M

  Shaare Zedek Medical Center · 2021

  The helmsley cancer center at shaare zedek medical center jerusalem

• $9.0M

  Mass General Brigham for the Brigham and Women'S Hospital · Boston, MA · 2023

  Pen-plus expansion

• $7.0M

  Engineering Ministries International USA · Colorado Springs, CO · 2022

  Alaska wash project

• $7.0M

  American Heart Association · Dallas, TX · 2024

  American heart association center for telehealth

• $6.8M

  Mass General Brigham for the Brigham and Women'S Hospital · Boston, MA · 2024

  Accelerating progress and promoting quality t1d care for the poorest billion through the global pen-plus partnership

• $6.7M

  Engineering Ministries International USA · Colorado Springs, CO · 2021

  Alaska wash project

• $6.6M

  Nevada Department of Health and Human Services · Carson City, NV · 2022

  Nevada first responder aed project

• $6.6M

  Geoscience Australia · 2022

  Digital earth africa - sustainable uptake and impact

• $6.4M

  Commonwealth Healthcare Corporation · 2023

  Cnmi chcc mri/medical equipment upgrade project

• $6.1M

  Yitzhak Shamir Medical Center · 2022

  Expansion and renovation of the cancer institute at shamir medical center

• $5.8M

  Ben-Gurion University of the Negev · 2024

  Construction of the leona m. And harry b. Helmsley charitable trust computer science building

• $5.7M

  Brigham and Women'S Hospital · Boston, MA · 2022

  Pen-plus expansion

• $5.6M

  Nebraska Department of Health & Human Services · Lincoln, NE · 2021

  Nebraska first responder aed project

• $5.4M

  Tzafon Medical Center · 2023

  The helmsley rehabilitation center of the north

• $5.3M

  Iowa Department of Public Health · Des Moines, IA · 2021

  Iowa first responder aed initiative

• $5.3M

  Hadassah Medical Organization · 2024

  Equipping the new hadassah - helmsley medical center, netivot

• $5.3M

  Bridges To Prosperity · Denver, CO · 2021

  Transformative connectivity in rural ethiopia

• $5.2M

  Shaare Zedek Medical Center · 2022

  The helmsley cancer center at shaare zedek medical center jerusalem

• $5.2M

  Shaare Zedek Medical Center · 2023

  Linear accelerators for the radiotherapy institute

• $5.1M

  The Baruch Padeh Medical Center Poriya · 2021

  The helmsley rehabilitation center of the north

• $5.0M

  Regents of the University of Minnesota · Minneapolis, MN · 2022

  Redefining the future of emergency medicine

• $5.0M

  Billings Clinic Foundation · Billings, MT · 2024

  Billings clinic surgical intensive care unit

• $5.0M

  Kapiolani Health Foundation · Honolulu, HI · 2024

  Martha b. Smith cancer & infusion center at kapiolani medical center for women & children

• $5.0M

  Stichting the Ocean Cleanup · 2024

  Develop and scale technologies to rid the oceans of plastics

• $5.0M

  The Queens Medical Center · Honolulu, HI · 2024

  The queen's medical center - west oahu cancer center expansion

• $5.0M

  Shaare Zedek Medical Center · 2023

  Development of the helmsley surgical wing

• $5.0M

  Stichting the Ocean Cleanup · 2023

  Develop and scale technologies to rid the oceans of plastics

• $5.0M

  Civica Foundation · Lehi, UT · 2021

  Affordable insulin biosimilars

• $4.9M

  St Rose Dominican Health Foundation · Henderson, NV · 2023

  Dignity health - st. Rose dominican - siena campus ecmo program

• $4.9M

  Fairview Health Services · Minneapolis, MN · 2023

  Improving survival outcomes through university of minnesota medical center ecmo center of excellence

• $4.9M

  Regents of the University of Minnesota · Minneapolis, MN · 2023

  Minnesota first responder aed project

• $4.9M

  Tel Aviv Sourasky Medical Center - Ichilov Hospital · 2024

  Construction of the sheltered -5 floor of the north tower

• $4.5M

  Baptist Medical Centre · 2024

  Elevating maternal and pediatric healthcare

• $4.5M

  Blue Circle Health · Wilmington, DE · 2024

  Development of blue circle health

• $4.5M

  Blue Circle Health · Wilmington, DE · 2024

  Development of blue circle health

• $4.5M

  The Baruch Padeh Medical Center Poriya · 2022

  The helmsley rehabilitation center of the north

• $4.4M

  World Health Organization · 2022

  Strengthening the capacity of the global diabetes compact

• $4.4M

  The Sheba Fund for Health Services and Research (Ra) · 2023

  The helmsley center for innovative surgical training

• $4.2M

  Altru Health System · Grand Forks, ND · 2024

  Altru health system ultrasound initiative

• $4.2M

  American Heart Association · Dallas, TX · 2023

  American heart association center for telehealth

• $4.2M

  Jerusalem College of Technology · 2022

  Helmsley faculty of life and health sciences building

• $4.1M

  The End Fund · New York, NY · 2023

  Reaching the last mile fund expansion

• $4.1M

  Zefat Academic College · 2021

  Equipping zefat academic college's inst. For adv. Health training & ed.

• $4.1M

  Clalit Health Services · 2022

  A new neonatal center for israels southern periphery at soroka medical center

• $4.0M

  Holy Rosary Healthcare Foundation · Miles City, MT · 2022

  Holy rosary healthcare comprehensive cancer center

• $4.0M

  Blue Circle Health · Wilmington, DE · 2024

  Development of blue circle health

• $3.9M

  Wilcox Health Foundation · Lihue, HI · 2024

  Wilcox medical center equipment revitalization project

• $3.9M

  Clalit Health Services · 2021

  Medical equipment for carmel medical center in haifa, israel

• $3.9M

  Hadassah Medical Organization · 2022

  Creating and equipping a new comprehensive diagnostic and interventional imaging center

• $3.8M

  Clalit Health Services · 2022

  Yoseftal hospital addition

• $3.8M

  St Alexius Medical Center · Bismarck, ND · 2024

  Chi st. Alexius health ultrasound initiative

• $3.7M

  New York University School of Medicine · New York, NY · 2023

  Tamale education and innovation center for health

• $3.7M

  Central Montana Medical Facilities · Lewistown, MT · 2023

  Cancer center at central montana medical center

• $3.7M

  T1d Exchange · Boston, MA · 2021

  Data approach to improve quality and outcomes for individuals with t1d

• $3.7M

  Bhsh System · Grand Rapids, MI · 2022

  Study the feasibility of telerobotic heart attack and stroke interventions

• $3.7M

  Helmholtz Zentrum Munchen (Gmbh) · 2021

  Identification of infants with high risk of t1d - primary prevention

• $3.6M

  The Sheba Fund for Health Services and Research (Ra) · 2022

  The helmsley center for innovative surgical training

• $3.5M

  Hillel Yaffe Medical Center · 2024

  Construction of pet-ct institute

• $3.5M

  Maccabi Healthcare Services · 2021

  Da vinci 4xi system dual console surgical robot and sterilization equip.

• $3.5M

  State of Nevada Department of Division of State Parks · Carson City, NV · 2024

  Valley of fire visitor center

• $3.5M

  State of Nevada Department of Division of State Parks · Carson City, NV · 2023

  Ice age fossil state park trails and outdoor amenities

• $3.5M

  State of Nevada Department of Division of State Parks · Carson City, NV · 2023

  Valley of fire visitor center

• $3.5M

  Blue Circle Health · Wilmington, DE · 2022

  Development of blue circle health

• $3.5M

  The Broad Institute · Cambridge, MA · 2024

  Novel therapeutic approaches for crohns disease

• $3.5M

  Blue Circle Health · Wilmington, DE · 2023

  Development of blue circle health

• $3.5M

  Indiana University · Indianapolis, IN · 2021

  Ampath model replication in ghana

• $3.5M

  Central Montana Medical Facilities · Lewistown, MT · 2022

  Cancer center at central montana medical center

• $3.3M

  Bar Ilan University in Israel · 2024

  The leona m. And harry b. Helmsley energy prototype lab at bar-ilan university

• $3.3M

  New Venture Fund · Washington, DC · 2021

  Type 1 diabetes camps project (2022 - 2024)

• $3.3M

  St Luke Health Care Foundation · West Chicago, IL · 2024

  Hope center for women and children

• $3.2M

  Bar Ilan University · 2023

  The leona m. And harry b. Helmsley energy prototype lab at bar-ilan university

• $3.2M

  Fairview Health Services · Minneapolis, MN · 2024

  Improving survival outcomes through university of minnesota medical center ecmo center of excellence

• $3.2M

  Hillel Yaffe Medical Center · 2024

  Eye institute and ambulatory surgery center

• $3.1M

  National Park Foundation · Washington, DC · 2022

  Little bighorn battlefield national monument visitor center

• $3.1M

  World Health Organization · 2024

  Strengthening the capacity of the global diabetes compact

• $3.1M

  World Health Organization · 2024

  Strengthening integrated prevention and control of chronic and severe ncds in the who african region, using t1d, scd, arf, and rhd as entry points

• $3.1M

  Renown Health Foundation · Reno, NV · 2022

  Simulation and innovation center at renown health

• $3.1M

  Clinton Health Access Initiative · Boston, MA · 2023

  Improving medical oxygen production and utilization

• $3.0M

  Brigham and Women'S Hospital · Boston, MA · 2021

  Global partnership to achieve universal access for t1d and ncds

• $3.0M

  St Luke Health Care Foundation · West Chicago, IL · 2023

  Hope center for women and children

• $3.0M

  Trinity Health · Minot, ND · 2024

  Trinity health ultrasound initiative

• $3.0M

  The Weizmann Institute of Science · 2024

  Early childhood development and community center at the weizmann institute of science

• $3.0M

  Tel-Aviv University · 2023

  Helmsley medical simulation center

• $3.0M

  The Weizmann Institute of Science · 2023

  Early childhood development and community center at the weizmann institute of science

• $3.0M

  Diabetes Nsw · 2022

  Improvements in outcomes for young people with diabetes in less-resourced countries

• $3.0M

  The Jewish Agency for Israel · 2022

  Flights for new immigrants from russia

• $3.0M

  Avera McKennan Hospital and University Health Center · Sioux Falls, SD · 2021

  Avera behavioral health center expansion

• $3.0M

  Jdrf T1d Fund Llc · Boston, MA · 2021

  Jdrf t1d fund phase iii

• $3.0M

  South Dakota Parks & Wildlife Foundation · Pierre, SD · 2021

  Custer state park bison center

• $3.0M

  The Broad Institute · Cambridge, MA · 2021

  Novel therapeutic approaches for crohns disease

• $3.0M

  Children'S Mercy Hospital · Kansas City, MO · 2022

  Type 1 diabetes rapid learning lab

• $3.0M

  Kmr Advancement of Medical Centers Ltd · 2021

  Establishment of the health discovery tower

• $2.9M

  Helmholtz Zentrum Munchen (Gmbh) · 2023

  Continuation of the gppad-02-study: identification of infants with increased type 1 diabetes risk for enrollment into primary prevention trials

• $2.9M

  Mass General Brigham for the Brigham and Women'S Hospital · Boston, MA · 2024

  Real-time post-op touchless, remote monitoring in crohns disease the sapphire trial

• $2.9M

  Sanford · Fargo, ND · 2022

  Sanford health ultrasound project

• $2.9M

  World Health Organization · 2023

  Strengthening integrated prevention and control of chronic and severe ncds in the who african region, using t1d, scd, arf, and rhd as entry points

• $2.9M

  Jerusalem College of Technology · 2021

  Helmsley faculty of life and health sciences building

View all 2,251 grants →

Who else funds this kind of work